Palvella Therapeutics, Inc. (PVLA) Free cash flow 2016–2023
Palvella Therapeutics, Inc. (PVLA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$13.9MFY2023 · since FY2016: -$14.9M → -$13.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$13.9M | +77.2% |
| FY2022 | -$61.0M | -608.2% |
| FY2021 | -$8.6M | +82.3% |
| FY2020 | -$48.6M | +11.5% |
| FY2019 | -$54.9M | -1887.3% |
| FY2018 | -$2.8M | -105.8% |
| FY2017 | $47.8M | +419.8% |
| FY2016 | -$14.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice